Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease

Código QR

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease

Yuan-Yuan Zhang,1,2* Yu-Chen Fan,3* Min Wang,1,2 Dong Wang,1,2 Xiao-Hong Li1,21Department of Neurology, Jinan Central Hospital affiliated to Shandong University, Jinan, People’s Republic of China; 2School of Medicine, Shandong University, Jinan, People’s Republic of China; 3Depar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang YY, Fan YC, Wang M, Wang D, Li XH
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Amyloid-beta Alzheimer disease Atorvastatin Inflammation Rat model Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/e81aa0cf14a34531a06cf79f768c06b7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Study of Histopathological Lesions in CA1 of the Hippocampus after Injection of Beta-Amyloid in a Rat Model of Alzheimer’s Disease
por: SM Hoseini,, et al.
Publicado: (2012)

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
por: Shima Mehrabadi, et al.
Publicado: (2021)

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
por: Sun LP, et al.
Publicado: (2018)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021)

A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
por: Xing Y, et al.
Publicado: (2017)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
por: Raquel Sanchez-Varo, et al.
Publicado: (2021)

Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation
por: Pandya V, et al.
Publicado: (2018)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
por: Kanubaddi KR, et al.
Publicado: (2018)

Effect of Beta asarone on concentration of TNF-α in a rat model of Alzheimer’s disease
por: Golshid Saki, et al.
Publicado: (2021)

Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001)

Higher Plasma APOC-III Was Associated with a Slower Reduction of β-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia
por: Zhang X
Publicado: (2020)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
por: Heeyoung Kang, et al.
Publicado: (2021)

Isoorientin Inhibits Amyloid β<sub>25–35</sub>-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway
por: Buyun Kim, et al.
Publicado: (2021)

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
por: Kitaguchi N, et al.
Publicado: (2018)

Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity
por: DÍAZ,JUAN CARLOS, et al.
Publicado: (2006)

The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
por: Javier Frontiñán-Rubio, et al.
Publicado: (2021)

Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy
por: Sumonto Mitra, et al.
Publicado: (2021)

Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain
por: Xiangpei Yue, et al.
Publicado: (2021)

Modeling clustered activity increase in amyloid-beta positron emission tomographic images with statistical descriptors
por: Shokouhi S, et al.
Publicado: (2015)

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
por: Jianfeng Wu, et al.
Publicado: (2021)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun JM, et al.
Publicado: (2021)

Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+ T Cell Proliferation: In vitro Pilot Study
por: Rosenberg,David R, et al.
Publicado: (2017)

Machine Learning to Predict Brain Amyloid Pathology in Pre-dementia Alzheimer’s Disease Using QEEG Features and Genetic Algorithm Heuristic
por: Nam Heon Kim, et al.
Publicado: (2021)

Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease
por: Saito Y, et al.
Publicado: (2020)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF ATORVASTATIN IN BULK DRUG, MARKETED TABLET AND NANOEMULSION FORMULATION
por: MUSTAFA,GULAM, et al.
Publicado: (2010)

A VALIDATED DENSITOMETRIC METHOD FOR ANALYSIS OF TELMISARTAN AND ATORVASTATIN CALCIUM IN FIXED DOSE COMBINATION
por: PATIL,U. P, et al.
Publicado: (2010)

Atorvastatin Has no Effects on Kidney Tissues of Wistar Albino Rats in the Long-Term Intake: An Electron Microscopic Study
por: Aktas,Ayfer, et al.
Publicado: (2011)

Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Rebecca M. Parodi-Rullán, et al.
Publicado: (2021)

FREQUENCY AND CORRELATES OF MYOPATHY IN PATIENTS WITH DIABETES TAKING ATORVASTATIN
por: Kamil Rehman Butt, et al.
Publicado: (2021)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Amyloid-ß-peptide reduces copper(II) to copper(I) independent of its aggregation state
por: OPAZO,CARLOS, et al.
Publicado: (2000)

EFFICACY OF ATORVASTATIN IN REDUCING PROTEINURIA IN PATIENTS OF CHRONIC KIDNEY DISEASE
por: Rizwan Azam, et al.
Publicado: (2019)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
por: I. K. Malashenkova, et al.
Publicado: (2018)

Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013)

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
por: Haiyan Liu, et al.
Publicado: (2021)

Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
por: Alaaeldin Eissa, et al.
Publicado: (2021)